BioMarin is a global pharmaceutical company focused on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients who live with serious and life-threatening rare genetic diseases.

Biotechnology

BioMarin Pharmaceutical

BioMarin Pharmaceutical's headquarters in San Rafael, CA, United States

Alexander Hardy

C. Greg Guyer

Brinda Balakrishnan

Brian R. Mueller

Cristin Hubbard

Amy Wireman

Eduardo von Pervieux

Gregory Friberg

G. Eric Davis

Greg Guyer

Eric Davis

Mantej Chhina

Shola Fafunso

Kei Nakamura

David Kirke

Marni Kottle

Elizabeth McKee Anderson

Timothy P. Walbert

Willard H. Dere

Maykin Ho

Mark Enyedy

Athena Countouriotis

Barbara Bodem

Ian T. Clark

Richard A. Meier

Robert Hombach

The Leadership Team at BioMarin Pharmaceutical is responsible for setting the strategic direction and overall vision of the company. Comprising senior executives from various functions, including research, finance, operations, and commercial strategy, the team ensures alignment across departments to drive innovation in developing therapeutics for rare genetic diseases, while also focusing on advancing organizational goals and fostering a collaborative corporate culture.

Leadership Team

The Commercial Operations and Strategy team at BioMarin Pharmaceutical plays a critical role in driving the company’s commercial success by developing and implementing strategic initiatives across various therapeutic areas. This team ensures effective product positioning and market access while optimizing operational efficiency through cross-functional collaboration. They support talent acquisition, compliance, and logistics, all while focusing on innovative strategies to enhance patient access to life-changing therapies for rare genetic diseases.

Commercial Operations and Strategy

The Research and Development team at BioMarin Pharmaceutical is dedicated to pioneering innovative therapeutics for rare genetic diseases. Comprising experts in disciplines such as pharmacology, process development, and clinical data systems, the team conducts cutting-edge research, oversees early clinical development, and ensures the safety and efficacy of new therapies. Their collaborative efforts aim to translate scientific discoveries into impactful treatments that improve patient outcomes.

Research and Development

The Quality Assurance and Compliance team at BioMarin Pharmaceutical ensures that all products and processes meet stringent regulatory standards and quality benchmarks. This team is responsible for overseeing compliance with Good Manufacturing Practices (GMP), managing global quality systems, and guaranteeing the integrity of analytics and supplier quality. Their efforts are crucial in maintaining the safety and effectiveness of therapeutics developed for patients with rare genetic diseases.

Quality Assurance and Compliance

The Clinical and Regulatory Affairs team at BioMarin Pharmaceutical is responsible for overseeing the planning, execution, and management of clinical trials to evaluate the safety and efficacy of new therapeutics. They ensure compliance with regulatory requirements, facilitate communication with health authorities, and manage data collection and analysis to support submissions for drug approval. This team plays a crucial role in advancing innovative treatments for patients with rare genetic diseases.

Clinical and Regulatory Affairs

��

BioMarin Pharmaceutical

Org chart

Board & advisors

Teams

Leadership Team

Commercial Operations and Strategy

Research and Development

Quality Assurance and Compliance

Clinical and Regulatory Affairs

Offices

��������

BioMarin Pharmaceutical

Org chart

Board & advisors

Teams

Leadership Team

Commercial Operations and Strategy

Research and Development

Quality Assurance and Compliance

Clinical and Regulatory Affairs

Offices

Related companies

��